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Purpose: To estimate the prevalence and causes of blindness and visual impairment, cataract 
surgical coverage (CSC), visual outcome of cataract surgery, and barriers to uptake cataract 
surgery in Timor-Leste.
Method: In a nationwide rapid assessment of avoidable blindness (RAAB), the latest popula-
tion (1,066,409) and household data were used to create a sampling frame which consists of 
2,227 population units (study clusters) from all 13 districts, with populations of 450–900 per 
unit. The sample size of 3,350 was calculated with the assumed prevalence of blindness at 4.5% 
among people aged $50 years with a 20% tolerable error, 95% CI, and a 90% response rate. 
The team was trained in the survey methodology, and inter-observer variation was measured. 
Door-to-door visits, led by an ophthalmologist, were made in preselected study clusters, and 
data were collected in line with the RAAB5 survey protocol. An Android smart phone installed 
with mRAAB software was used for data collection.
Result: The age–gender standardized prevalence of blindness, severe visual impairment, and 
visual impairment were 2.8%, (1.8–3.8), 1.7% (1.7–2.3), and 8.1% (6.6–9.6), respectively. 
Cataract was the leading cause of blindness (79.4%). Blindness was more prevalent in the older 
age group and in women. CSC was 41.5% in cataract blind eyes and 48.6% in cataract blind 
people. Good visual outcome in the cataract-operated eyes was 62% (presenting) and 75.2% 
(best corrected). Two important barriers to not using available cataract surgical services were 
accessibility (45.5%) and lack of attendants to accompany (24.8%).
Conclusion: The prevalence of blindness and visual impairment in Timor-Leste remains high. 
CSC is unacceptably low; gender inequity in blindness and CSC exists. Lack of access is the 
prominent barrier to cataract surgery.
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Introduction
Blindness and visual impairment are persistent global challenges despite the fact that 
nearly 80% of the causes are avoidable and 90% of those affected live in developing 
countries.1–9 Timor-Leste (East Timor) is a young nation in the South-East Asian 
region. Since independence in 1999, Timor-Leste has made significant progress in 
political stability, peace, and socioeconomic development. But it lags behind in some 
of the vital health status indicators such as the infant mortality rate (IMR), maternal 
mortality rate (MMR), vaccination coverage, undernutrition, and many infectious 
diseases including tuberculosis, malaria, and leprosy.10
The country is divided into 13 districts, 65 subdistricts, 442 suco (villages), and 
2,225 aldea/villages. According to the 2010 census, Timor-Leste has a population of 
1.06 million (males 51% and females 49%) and 10.3% are aged $50 years.11 It has 
one referral hospital in the capital, Dili, which provides general eye care services 
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including correction of refractive error and cataract surgery; 
additionally, two provincial eye clinics provide primary eye 
care and refraction services.
The Ministry of Health (MoH) is working to establish 
and maintain a cost-effective health system, and eye health 
has been included in the strategic planning framework in 
recognition of the significant economic and social impact 
of blindness.
The East Timor Eye Program (ETEP) initiated in 2000 by 
the Royal Australasian College of Surgeons (RACS) included 
mobile eye care services by visiting volunteer Australian 
ophthalmologists. A permanent eye care service was estab-
lished in Dili in 2004. The Fred Hollows Foundation, New 
Zealand, joined the initiative in 2005. Since then, .10,000 
cataract surgeries have been performed with annual surgical 
outputs of .1,200 in recent years.12
A prevalence of blindness study conducted in 2005 in 
Bobonaro and Dili districts of Timor-Leste led to the publi-
cation of first data on eye care services in Timor-Leste. That 
study reported 4.1% blindness and 17.7% visual impair-
ment among the population aged $40 years.13 The leading 
causes of blindness and visual impairment were cataract 
and uncorrected refractive error (URE), respectively. Based 
on the findings of the survey, a master plan in eye care was 
developed to expand eye care services through extensive 
community outreach, infrastructure, and human resource 
development. A repeat survey in the same population (2010) 
reported that the gender–age–domicile adjusted prevalence 
of blindness was 7.7% for visual acuity of 6/60 and 3.6% for 
visual acuity of 3/60 among Timorese aged $40 years.14 This 
study indicated that prevalence and causes of blindness were 
unchanged over the 5 years. A study in nearby rural Indonesia 
around the same time showed that blindness was 2.2% (all 
ages) and cataract was the leading cause of bilateral blindness 
(62.5%).15 In urban Indonesia, the prevalence of blindness was 
lower at 1.12% among those aged $40 years.16
Over the previous 15 years, there was some development 
in eye care services as a result of a collaborative effort by the 
government and international non-governmental organiza-
tions (INGOs). In 2015, the ETEP was handed over to the 
MoH with a phasing out of support from external develop-
ment partners. Therefore, the MoH, Timor-Leste, decided to 
carry out a rapid assessment of avoidable blindness (RAAB) 
survey to assess the impact of on-going eye care service and 
to design the country-specific eye health strategic plan in line 
with the WHO Global Action Plan 2014–2019.17 The aim of 
the present study was to estimate the prevalence and causes of 
blindness and visual impairment, cataract surgical coverage 
(CSC), visual outcome of cataract surgery, and barriers to 
uptake of cataract surgery in Timor-Leste.
Method
The sample size was calculated with an expected preva-
lence of blindness of 4.5% (among people $50 years) with 
a tolerable β error of 20%, a non-compliance of 10%, and 
confidence levels of 95%. The design effect correction factor 
(DEFF) was 1.5 to compensate in sample size for the decrease 
in variation caused by the cluster sampling of 50 people in 
each cluster. Using these assumptions with the 2010 census 
data, the sample size was calculated at 3,336 in 67 study 
clusters. In order to achieve this, we subdivided the country 
into districts, subdistricts, sucos, and aldea (villages). The 
average population size of a village is 473, which repre-
sented an appropriate population unit to form a study cluster. 
Therefore, the list of all 2,227 villages across the 13 districts 
of the country comprised the sampling frame from which 
67 villages were selected with a probability proportional 
to size. Among the selected villages, if the population 
was .1,000, it was divided as per compact segment sampling 
procedures and if ,500 an adjacent village(s) was randomly 
chosen and combined to form the study cluster.
The data collection was preceded by a 4-day training of 
the field teams and a pilot study. Three survey teams were 
trained, of which two teams at any time were mobilized for 
field work, led by a local ophthalmologist. The training was 
carried out by a certified RAAB trainer (YS) and covered all 
survey team members.
The study teams were trained for data collection and were 
assessed for the inter-observer variability (IOV) in assess-
ment of participants. The IOV was carried out in a village 
hall of a non-study cluster where 50 people aged $50 years 
were invited to undergo an eye examination. All three teams 
examined the same person for visual acuity, lens status, and 
assigning the cause of vision impairment if the presenting 
vision was worse than 6/18. The findings were masked 
between examination teams and entered into the IOV data 
entry RAAB5 software.
Detailed maps of selected study clusters were obtained 
and prepared prior to the data collection work. The direc-
tion of the starting point in the cluster was randomly chosen 
though it was usually from the local health post situated in 
the village. Selected eligible households were enrolled in the 
study in house-to-house visits until 50 people aged $50 years 
were enrolled in each cluster.
After enrollment and verbal consent, the demographics 
(age, gender, and habitat) and history of spectacle use were 
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recorded. The presenting distance visual acuity was measured 
using a standardized tumbling E card. Pinhole visual acuity 
was tested in all eyes with visual acuity ,6/18. The anterior 
segment eye examination was done initially with a flashlight. 
A direct ophthalmoscope assessed the media clarity and was 
further used for fundus examination. A dilated eye examina-
tion (with Tropicamide 1%) was performed if pinhole vision 
was worse than 6/18 unless there was obvious cataract or 
corneal opacity. Ocular surgery history and related infor-
mation such as the date, location, and cost of surgery were 
recorded for those who had undergone eye surgery in the 
past. The barriers to cataract surgery were recorded in those 
who had visual acuity ,6/18 in either eye due to cataract. 
Appropriate medications, prescriptions, and referrals were 
done after the examination. If the enrolled person was not 
found in the house and/or not returning in a couple of days, 
their vision status was obtained from the family members 
or the neighbors and the record was marked as unavailable 
for eye examination.
Data collection in this study was paperless. All findings 
were entered into a smartphone where the mRAAB software 
was installed. This software has screens for demography, 
visual acuity, and ocular examination findings. The data 
entry permits an incomplete data entry “as save” and allows 
a later completion for those who need a dilated eye examina-
tion. The software mRAAB has in-built validation rules and 
consistency checks and provides the option for checking of 
data before final saving by review screen. Inconsistencies or 
errors, if any, are shown in the review screen when the study 
participant was still present.
Blindness, severe visual impairment, and moderate visual 
impairment with presenting visual acuity (PVA) ,3/60, 
6/60, and 6/18 in the better eye, respectively, were defined 
as per the WHO classification.18 The following formula was 
used for CSC.
CSC in person: The proportion of people with bilateral 
cataract eligible for cataract surgery who have received 
cataract surgery in one or both eyes.
CSC in eyes: The proportion of cataract eyes that received 
cataract surgery (at 3/60, 6/60, and 6/18 levels).
We used the following statistical methods for data 
analysis: 1) the estimated prevalence of visual impairment 
and blindness and those attributed specifically to cataract; 
2) 95% CI, and 3) odds ratio (OR) to assess risk factors
on blindness and CSC. We considered a P-value ,0.05 as
significant.
The RAAB survey protocol is one of the methods of data 
collection for blindness surveys recommended in the WHO 
Global Action Plan 2014–2019.16 It has been implemented 
in more than 70 countries worldwide.19 The study protocol in 
Timor-Leste RAAB was in accordance with the Declaration 
of Helsinki for human research ethics. The protocol was 
approved by the National Health Research Committee, MoH, 
Timor-Leste (July 10, 2016). Verbal informed consent was 
obtained from each study participant before the eye examina-
tion, and the participants were told that the participation was 
voluntary and that they were free to withdraw at any point. 
It was always explained that the name and identification of 
the study participant would not appear in any form of report 
generated from this study. No monetary incentive was offered 
for participation in this study.
Results
The findings of inter-observer agreement Kappa analysis 
were 0.65 for presenting vision and 0.75 for assigning the 
principal cause of visual impairment within acceptable range 
according to the RAAB survey instruction manual.
Age and gender distribution of Timor-Leste Census 
2010 data for the population and study participants showed 
a fairly similar pattern of distribution. The 80–99 and the 
60–69 years age groups were slightly overrepresented in 
the sample, while the 70–79 and the 50–59 years age groups 
were slightly underrepresented (Table 1). These variations 
were adjusted in the survey results and presented as age–
gender adjusted results.
Of the 3,350 enrolled eligible residents, 97.1% (n=3,253) 
participated in the study. Among the examined population, 
48.5% were male and 51.5% were female. Age and gender 
distribution of enrolled vs examined people is shown in 
Table 2.
Prevalence of blindness and visual 
impairment
The overall age- and gender-adjusted prevalence of blindness 
with PVA ,3/60 was 2.8% in persons and 4.6% among the 
eyes. The prevalence of blindness in females was relatively 
higher at 3.1% compared to males at 2.4% (OR 1.4, 95% 
CI 0.9–2.1, P=0.1), and was statistically not significant 
(Table 3).
Table 1 Comparison on sample vs census population data
Age group, years Sample, % Census, %
50–59 49.2 51.7
60–69 35.7 31.9
70–79 10.5 13.7
80–99 4.5 2.7
all 100.0 100.0
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The age- and gender-adjusted prevalence of severe visual 
impairment with PVA ,6/60 was 4.5% (Male: 4.0%, Female: 
4.9%); the prevalence of moderate visual impairment with 
PVA ,6/18 was 12.5% (Male: 12.0%, Female 13.1%); and 
the crude prevalence of blindness with visual acuity ,3/60 
was 3.0% (Male: 2.5%, Female: 3.4%). The crude prevalence 
of blindness increased substantially with increasing age in 
both genders (Table 4).
Causes of blindness
Cataract was the leading cause of bilateral blindness repre-
senting 79.4% of overall blindness. Other major causes of 
blindness were posterior segment problem (6.2%), glaucoma, 
and globe anomalies (5.2% each) (Table 5).
Cataract is still the leading cause of severe visual impair-
ment and moderate visual impairment among the Timorese 
population. URE contributed to almost one-third (32.2%) of 
moderate visual impairment (Table 6).
Cataract surgical coverage
Age–gender adjusted CSC in Timor is low among the cata-
ract blind people (48.6%) and cataract blind eyes (41.5%). 
The situation is worse in female gender (31.3% and 30.4%, 
respectively) (Table 7).
Visual outcome of cataract surgery
In addition to low CSC, the surgical outcome is not meet-
ing the WHO standard of .80% operated eyes achieving 
6/18 or better. Based on the presenting and best-corrected 
visual acuities, good visual outcome of cataract surgery 
was recorded in 62% and 75.2% of cataract-operated 
eyes, respectively (Table 8). Adequate optical correc-
tion could considerably improve the visual outcome after 
cataract surgery.
The survey revealed that the visual outcomes have not 
improved in recent years despite the advancement of tech-
nology in cataract surgery. Conversely, the “good outcome” 
has declined from 77.8% 7 years ago to 57% in recent years 
(Table 9). More than half (52.4%) of the poor outcome fol-
lowing cataract surgery was related to long-term complica-
tions of surgery such as posterior capsule opacification and 
retinal detachment, and one-third (33.3%) were due to sur-
gical complications. Among the borderline visual outcome, 
45.2% were due to URE and 38.7% were due to long-term 
complications of cataract surgery (Table 10).
Barriers to uptake of available cataract 
surgical services
Eye care services in Timor-Leste are free. However, this 
does not include indirect costs such as travel, accommoda-
tion, food, and wage loss of an accompanying person. The 
Table 2 Description of enrolled and examined participants
Study 
participants
Enrolled Examined Not available/
refused
Response 
rate, %
Males 1,629 1,577 52 96.8
Females 1,721 1,676 45 97.4
all 3,350 3,253 97 97.1
Table 3 age- and gender-adjusted prevalence of blindness and 
visual impairment
VA category Males Females All
% 95% CI % 95% CI % 95% CI
Blindness-VA ,3/60 in the better eye with available correction 
(presenting VA)
all bilateral cases 2.4 1.1–3.6 3.1 2.0–4.3 2.8 1.8–3.8
all eyes 4.7 3.4–6.0 4.5 3.4–5.7 4.6 3.6–5.7
VA ,6/60 in the better eye with available correction (PVA)
all bilateral cases 4 2.5–5.4 4.9 3.4–6.5 4.5 3.2–5.7
all eyes 6.8 5.3–8.3 6.7 5.2–8.3 6.8 5.5–8.1
VA ,6/60 in the better eye with available correction (PVA)
all bilateral cases 12 9.5–14.4 13.1 10.7–15.4 12.5 10.5–14.6
all eyes 15.9 13.5–18.3 16.3 13.9–18.8 16.1 14.1–18.1
Abbreviations: Va, visual acuity; PVa, presenting visual acuity.
Table 4 Age-specific prevalence of blindness (%): PVA ,3/60 
according to gender
Age 
group, 
years
Males %, n, 
(total 
examined)
Females %, n, 
(total 
examined)
All %, n, 
(total 
examined)
50–59 years 0, 0, (789) 0.5, 4, (812) 0.2, 4, (1,601)
60–69 years 2.2, 12, (550) 2.6, 16, (611) 2.4, 28, (1,161)
70–79 years 10, 17, (170) 8.1, 14, (173) 9.0, 31, (343)
80+ years 16.2, 11, (68) 28.8, 23, (80) 23.0, 34, (148)
Total 2.5, 40, (1,577) 3.4, 57, (1,676) 3.0, 97, (3,253)
Abbreviations: n, number examined; PVa, presenting visual acuity.
Table 5 Causes of blindness
Causes of 
blindness
Males Females All
n Male, % n Female, % n All, %
Principal causes of blindness in people: PVA ,3/60 in 
better eye
Cataract 28 70.0 49 86.0 77 79.4
non-trachomatous 
corneal opacity
2 5.0 0 0.0 2 2.1
Phthisis 0 0.0 2 3.5 2 2.1
glaucoma 4 10.0 1 1.8 5 5.2
Posterior segment 
disease
5 12.5 1 1.8 6 6.2
globe/Cns 1 2.5 4 7.0 5 5.2
Total 40 100 57 100 97 100
Abbreviations: Cns, central nervous system; n, number; PVa, presenting visual 
acuity.
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accessibility to service and lack of attendant were the main 
barriers at 45.5% and 24.8%, respectively (Table 11).
Discussion
The current RAAB is a nationwide study in Timor-Leste 
unlike the previous surveys which were limited to a few 
selected districts around the capital city, Dili. All the popula-
tion within the districts had an equal chance to get included 
as village-based clusters were selected with a probability 
proportional to size. As a result, this survey has the power 
to generalize results to formulate national planning for eye 
care services. The response rate at 97.1% was high with very 
few refusals or absentees.
Although the findings of this survey cannot be directly 
compared to the previous surveys as different age groups 
($50 years in the current study and $40 years in past studies) 
were sampled, it is clear that the prevalence of blindness 
has reduced in Timor-Leste compared to results in 2005 
and 2010. The current age- and gender-adjusted prevalence 
of blindness is 2.8% (n=3,084) in people aged $50 years. 
The blindness is higher among females at 3.1% compared to 
males at 2.4% though statistically not significant. This gender 
inequality was not reported in previous surveys carried out 
in this country.
It is not surprising that cataract is the leading cause of 
blindness though the fact that this prevalence is nearly 30% 
more than the global prevalence is surprising.20 Glaucoma 
and traumatic corneal opacity are other major causes of blind-
ness in the country. As trachoma (TT) has been identified 
in some areas of the country, a detailed trachoma survey 
is warranted.
Although most of the bilateral blindness in the country is 
due to cataract and .90% of surgeries are done for cataract, 
the CSC is very low (,50% in all three visual acuity catego-
ries, among the people and in eyes). The CSC among females 
is significantly lower, nearly half that of cataract blind eyes 
in males (OR 0.65, 95% CI 0.62–0.69, P#0.01). This finding 
was not reported in previous surveys.
Overall, there were fairly good visual outcomes 
(PVA $6/18) of cataract surgery in Timor-Leste at 62%; but 
this does not meet the WHO recommendations of .80%. The 
declining proportion of good outcome over the years despite 
the advances in surgical techniques and technology in cata-
ract surgery is indeed alarming. In the poor outcome group, 
Table 6 Causes of severe visual impairment
Causes Males Females All
n % n % n %
Principal causes of severe visual impairment in people: 
PVA ,6/60–3/60
refractive error 1 3.7 0 0.0 1 1.8
Cataract 25 92.6 29 100.0 54 96.4
non-trachomatous corneal opacity 1 3.7 0 0.0 1 1.8
Total 27 100.0 29 100.0 56 100.0
Principal causes of moderate visual impairment in people: 
PVA ,6/18–6/60
refractive error 53 40.5 33 24.3 86 32.2
Cataract 73 55.7 99 72.8 172 64.4
Cataract surgical complications 3 2.3 1 0.7 4 1.5
Trachomatous corneal opacity 0 0.0 1 0.7 1 0.4
non-trachomatous corneal opacity 0 0.0 1 0.7 1 0.4
glaucoma 1 0.8 0 0.0 1 0.4
Other posterior segment disease 0 0.0 1 0.7 1 0.4
all other globe/Cns abnormalities 1 0.8 0 0.0 1 0.4
Total 131 100.0 136 100.0 267 100.0
Abbreviations: Cns, central nervous system; PVa, presenting visual acuity.
Table 7 Age- and gender-adjusted cataract surgical coverage (%)
Visual 
acuity
Males Females OR, 95% CI, and P-value, 
compared with males
All
Cataract surgical coverage in eyes (percentage)
,3/60 52.6 30.4 OR 0.4 (95% CI 0.2–0.6, P,0.01) 41.5
,6/60 40.3 22.0 OR 0.4 (95% CI 0.2–0.8, P,0.01) 30.9
,6/18 23.5 11.3 OR 0.4 (95% CI 0.2–0.9, P=0.02) 16.8
Cataract surgical coverage in people (percentage)
,3/60 65.8 31.3 OR 0.2 (95% CI 0.1–0.4, P,0.01) 48.6
,6/60 51.4 26.4 OR 0.3 (95% CI 0.2–0.6, P,0.01) 38.1
,6/18 31.0 15.5 OR 0.4 (95% CI 0.2–0.8, P=0.01) 22.4
Table 8 Visual outcome among the cataract-operated eyes
Non-IOL IOL All
Eyes % Eyes % Eyes %
Outcome PVA
good outcome 2 66.7 83 61.9 85 62.1
Borderline 0 0.0 31 23.1 31 22.6
Poor 1 33.3 20 14.9 21 15.3
Total 3 100 134 100 137 100
Outcome BCVA
good outcome 2 66.7 101 75.4 103 75.2
Borderline 0 0.0 16 11.9 16 11.7
Poor 1 33.3 17 12.7 18 13.1
Total 3 100 134 100 137 100
Note: WHO defines the visual outcome of cataract surgery as good for vision .6/18, 
borderline for vision ,6/18–6/60, and poor for vision ,6/60.
Abbreviations: BCVa, best-corrected visual acuity; iOl, intraocular lens; PVa, 
presenting visual acuity; WhO, World health Organization.
Table 9 Visual outcome in operated eyes by years after surgery
Visual 
outcome
,3 years 4–6 years .7 years
Eyes % Eyes % Eyes %
good outcome 49 57.0 15 62.5 21 77.8
Borderline 22 25.6 4 16.7 5 18.5
Poor 15 17.4 5 20.8 1 3.7
Total 86 100 24 100 27 100
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seven of 21 (33%) eyes had intraoperative complications and 
among the borderline outcome group, 14 of 31 (45.2%) eyes 
had URE. These findings clearly suggest that there is scope 
for further improvement of visual outcome by improving 
surgical quality and optical services, including biometry. The 
prominent barriers among unoperated cataract blind people 
were the accessibility issues such as non-proximity of surgical 
services and lack of an accompanying attendant. This could 
have contributed to obvious gender disparity in CSC.
There were two limitations in this study: 1) the blind-
ness definition included only the visual acuity (,3/60) and 
not the visual field; 2) the posterior capsular opacification 
was considered a post cataract surgery complication. In the 
absence of a visual field analyzer available in the system, the 
visual field was not included in the definition of blindness. 
Similarly, in the absence of a laser capsulotomy service (YAG 
Laser) the posterior capsule opacification was included as one 
of the post cataract surgery complications. The strength of 
the study was its nationwide inclusion, a systematic exami-
nation of the recruits using the accepted standards RAAB, 
and a good response.
Conclusion
In Timor-Leste, the prevalence of blindness and visual 
impairment is still challengingly high, although it has 
reduced compared to earlier surveys. Gender equity, quality, 
and accessibility issues for the services must be addressed 
to improve the general quality of eye care services of the 
country. Focus of intervention should be on reducing cata-
ract blindness.
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